News Archive
DTR - Shares in Issue
In accordance with the FSA's Disclosure and Transparency Rules, Eden confirms that as of 30 June 2011 the Company has 99,303,596 Ordinary Shares of 1p each in issue.
The voting rights of all of these shares are identical.
The Directors of Eden are responsible for the contents of this announcement.
Enquiries:
Eden Research plc
01993 862761
Clive Newitt, Managing Director
St Helens Capital Partners LLP
020 7368 6959
Mark Anwyl
Notes:
Eden's strategy is focused on the development and commercialisation of its terpene-based encapsulation technology for agricultural and non-agricultural uses through appropriate regional or global partnerships.
Terpenes are natural compounds which function as defence mechanisms in many plant groups and are released in response to infection, attack by pests, stress or mechanical injury. Terpenes are already widely used in the food flavouring, cosmetic and pharmaceutical industries.
Historically, terpenes have had limited commercial use in the agrochemical sector due to their volatility, phytotoxicity and poor solubility. Eden's platform encapsulation technology provides the unique, natural solution to these problems and enables terpenes to be used as effective, low-risk agrochemicals.